Medindia » Medication Manual » Rimonabant

Rimonabant

Latest prescription information about Rimonabant. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
Email Email print Print Save this page Save Syndicate Syndicate
Generic Name : Rimonabant
Therapeutic Classification : Antiobesity Drug
ICD Code : Y52.6
Trade Name(s): 
International- Acomplia, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, Zimulti, and Riomont.
Why it is prescribed (Indications) : 
This medication is an anorectic anti-obesity agent, prescribed for obesity and management of body weight as adjunct to diet and exercise.  It blocks endogenous cannabinoid binding to neuronal CB1 receptors.
When it is not to be taken (Contraindications): Hypersensitivity.

Pregnancy Category :

A B C D X
Category N : Not yet classified.

Dosage & When it is to be taken : 
PO- The usual dose is one 20mg tablet to be taken once daily.
How it should be taken : 
It comes as a tablet to take by mouth, before breakfast.
Warnings and Precautions : 
* Caution should be exercised in patients with history of liver or kidney impairment, epilepsy, who are taking other medications, any allergy, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication.
Side Effects : 
Gastrointestinal - Nausea, loss of appetite, dry mouth, vomiting, gastrointestinal disorders, diarrhea.
Central Nervous System - Dizziness, mood changes, sleep disorder, diarrhea, depression, anxiety, memory loss.
Skin - Itching, excessive sweating.
Musculoskeletal - Muscle cramps or spasm, tendon pain and inflammation, back pain and joint sprain.
Other Precautions : 
* Avoid excess dosage.
Storage Conditions : 
Store the medication as directed by your physician.

Related News

Anti-obesity Drug 'Rimonabant' may Face a Ban Following Fear of Psychiatric Side Effects

The anti-obesity drug 'Rimonabant' is likely to face a ban in India, after studies in Europe found a likelihood of psychiatric side effects upon use of the drug. The drug, manufactured by the ...
Rimonabant Approved for Use in NHS

Controversial diet drug, rimonabant, has been approved for use on the NHS despite indications that the drug may trigger suicidal behavior. The National Institute for Health and ...
Studies Show Concern Over Weight-loss Drug Rimonabant

Two overviews of trials of weight-loss drugs have added to concerns that the obesity treatment rimonabant may boost the risk of depression and anxiety. The papers, published in ...
UK Reports Psychiatric Reactions to Weight-loss Drug Rimonabant

Even as the European Medicines Agency (EMEA) warned patients on anti-depressants against taking weight loss drug rimonabant, the Department of Health's Medicines and Healthcare products Regulatory ...
20 Mg Rimonabant Per Day may Help to Quit Smoking

Using rimonabant at a dose of 20 mg per day can help people quit smoking, can help them to remain abstinent, and can help prevent the weight gain that so often accompanies attempts at stopping ...

Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

Browse the Drugs alphabetically

Reference  

  • Food and Drug Administration (FDA)
  • National Institutes of Health (NIH)
  • PubMed
  • CIMS
  • Indian Pharma Reference Guide 2012
Drugs Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z